These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21290178)

  • 41. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
    Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How to measure glucocorticoid receptor's sensitivity in patients with stress-related psychiatric disorders.
    Leistner C; Menke A
    Psychoneuroendocrinology; 2018 May; 91():235-260. PubMed ID: 29449045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
    Schinke C; Hesse S; Rullmann M; Becker GA; Luthardt J; Zientek F; Patt M; Stoppe M; Schmidt E; Meyer K; Meyer PM; Orthgieß J; Blüher M; Kratzsch J; Ding YS; Then Bergh F; Sabri O
    Stress; 2019 Jan; 22(1):93-102. PubMed ID: 30369292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidality.
    Hubers AA; van der Mast RC; Pereira AM; Roos RA; Veen LJ; Cobbaert CM; van Duijn E; Giltay EJ
    J Neuroendocrinol; 2015 Mar; 27(3):234-44. PubMed ID: 25565388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals.
    Fuss J; Claro L; Ising M; Biedermann SV; Wiedemann K; Stalla GK; Briken P; Auer MK
    Psychoneuroendocrinology; 2019 Jun; 104():228-237. PubMed ID: 30897530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serotonin transporter gene and stress reactivity in unipolar depression. Role of the HPA system as endophenotype of the SLC6A4 gene].
    Welper H; Aller A; Guttenthaler V; Höfels S; Lennertz L; Pfeiffer U; Schwab SG; Zobel A
    Nervenarzt; 2014 Mar; 85(3):336-8, 340-3. PubMed ID: 23325311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPA-axis stress reactivity in youth depression: evidence of impaired regulatory processes in depressed boys.
    Lopez-Duran NL; McGinnis E; Kuhlman K; Geiss E; Vargas I; Mayer S
    Stress; 2015; 18(5):545-53. PubMed ID: 26115161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation of HPA axis related genes in men with hypersexual disorder.
    Jokinen J; Boström AE; Chatzittofis A; Ciuculete DM; Öberg KG; Flanagan JN; Arver S; Schiöth HB
    Psychoneuroendocrinology; 2017 Jun; 80():67-73. PubMed ID: 28319850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prenatal stress programs neuroendocrine stress responses and affective behaviors in second generation rats in a sex-dependent manner.
    Grundwald NJ; Brunton PJ
    Psychoneuroendocrinology; 2015 Dec; 62():204-16. PubMed ID: 26318631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The HPA Axis as Target for Depression.
    Menke A
    Curr Neuropharmacol; 2024; 22(5):904-915. PubMed ID: 37581323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T; Python A; Schulz PE; Aubry JM
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
    Reppermund S; Zihl J; Lucae S; Horstmann S; Kloiber S; Holsboer F; Ising M
    Biol Psychiatry; 2007 Sep; 62(5):400-6. PubMed ID: 17188252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.